Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Douglas Smith currently holds 11,285 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Douglas Smith has been a net seller of JAZZ stock. They have purchased $28.3K and sold $1.6M worth of shares.
Mark Douglas Smith's most recent insider trade was on Aug 5, 2026, when they sold 1,605 shares at $0.00 per share.
Mark Douglas Smith serves as Executive at Jazz Pharmaceuticals plc (JAZZ). They have executed 39 insider transactions totaling $1.6M over their tenure at the company.
Mark Douglas Smith holds the position of Executive at Jazz Pharmaceuticals plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Mark Douglas Smith has shown a selling trading pattern, with $28.3K in total purchases and $1.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Douglas Smith was on Jul 2, 2025, when they sold $203.0K worth of PHR shares. This transaction involved 7,000 shares at $29.00 per share.
Mark Douglas Smith currently owns 11,285 shares of Jazz Pharmaceuticals plc (JAZZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Douglas Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Douglas Smith has 39 Form 4 filings on record as an insider at Jazz Pharmaceuticals plc.
Set alerts for Mark Douglas Smith and 40,000+ other insiders.